Related Experiment Videos
A multiple transgenic mouse model with a partially humanized activation pathway for helper T cell responses
1Interdisciplinary Center of Clinical Research, University of Leipzig, Leipzig, Germany. laur@server3.medizin.uni-leipzig.de
Journal of Immunological Methods
|December 21, 2000
Summary
This study introduces CD4/DR3 mice, a novel model expressing human CD4 and HLA-DR3. These mice accurately mimic human immune responses, aiding research into autoimmune diseases and T cell therapies.
Area of Science:
- Immunology
- Transgenic animal models
- Autoimmunity
Background:
- Human CD4 and MHC II molecules are crucial for immune responses.
- Existing transgenic models often have disturbed T cell subsets.
- A need exists for accurate humanized models to study autoimmunity.
Purpose of the Study:
- To develop a novel mouse model expressing human CD4 and HLA-DR17 (HLA-DR3).
- To assess the functionality of human CD4 and HLA-DR3 expression in vivo.
- To evaluate the utility of this model for studying autoimmune diseases and T cell-based therapies.
Main Methods:
- Generation of CD4/DR3 transgenic mice lacking murine cd4.
- Analysis of CD4 and HLA-DR3 expression on immune cells.
- In vitro recall responses to tetanus toxoid using anti-HLA-DR and anti-CD4 monoclonal antibodies.
Main Results:
- Human CD4 accurately replaced murine cd4, preserving CD4+ and CD8+ T cell subsets.
- Human CD4 was expressed on antigen-presenting cells, closely resembling human patterns.
- T cell stimulation depended on human transgene products, blocked by specific monoclonal antibodies.
Conclusions:
- CD4/DR3 mice represent a valuable, partially humanized model for studying DR3-associated autoimmune responses.
- This model facilitates in vivo investigations of therapeutic strategies targeting human CD4.
- The model supports research into the immunopathogenesis of human autoimmune diseases.